Rocket Pharmaceuticals Warrant
RCKTW
17 hedge funds and large institutions have $1.22M invested in Rocket Pharmaceuticals Warrant in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
6% more funds holding
Funds holding: 16 → 17 (+1)
0.78% less ownership
Funds ownership: 4.13% → 3.35% (-0.78%)
75% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 4
77% less capital invested
Capital invested by funds: $5.39M → $1.22M (-$4.17M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
Radcliffe Capital Management
Bala Cynwyd,
Pennsylvania
|
+$13.5K |
| 2 |
Walleye Capital
New York
|
+$7.18K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$16 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Clear Street
New York
|
-$44.1K |
| 2 |
SIM
Sandia Investment Management
Boston,
Massachusetts
|
-$38.6K |
| 3 |
BFM
Boothbay Fund Management
New York
|
-$32.1K |
| 4 |
HF
HRT Financial
New York
|
-$6.81K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$4.41K |
RCKTW Hedge Fund Activity: Q3 2023 in Review
17 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in Rocket Pharmaceuticals Warrant (RCKTW) for Q3 2023, worth a combined $1.22M — down 77% from $5.39M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new RCKTW positions and 1 closed out — a net gain of 1 holder — while 1 added to existing stakes and 4 trimmed.
The largest buyer was Radcliffe Capital Management, opening a new position worth an estimated $13.5K. The largest seller was Clear Street, cutting an estimated $44.1K.
- 17 institutional investors held Rocket Pharmaceuticals Warrant (RCKTW) as of Q3 2023, up from 16 in Q2 2023.
- Funds reported $1.22M of Rocket Pharmaceuticals Warrant stock for Q3 2023, down 77% quarter-over-quarter.
- 2 funds opened new Rocket Pharmaceuticals Warrant positions in Q3 2023 and 1 closed out, a net change of +1 holder.
- The largest Rocket Pharmaceuticals Warrant buyer in Q3 2023 was Radcliffe Capital Management, an estimated $13.5K added.
- The largest Rocket Pharmaceuticals Warrant seller in Q3 2023 was Clear Street, an estimated $44.1K sold.
Based on aggregated 13F filings for Q3 2023.